Clinical trials
Hypertension trials in Argentina
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
71 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 2 |
| 2004 | 1 |
| 2005 | 3 |
| 2006 | 8 |
| 2007 | 5 |
| 2008 | 8 |
| 2009 | 3 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 2 |
| 2013 | 3 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 3 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 4 |
| 2025 | 9 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 42 |
| Terminated | 10 |
| Recruiting | 7 |
| Active, not recruiting | 6 |
| Unknown status | 3 |
| Not yet recruiting | 1 |
| Enrolling by invitation | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 8 |
| Novartis Pharmaceuticals | 7 |
| Boehringer Ingelheim | 6 |
| Takeda | 5 |
| Eli Lilly and Company | 4 |
| Gilead Sciences | 4 |
| Novartis | 4 |
| Sanofi | 3 |
| GlaxoSmithKline | 2 |
| United Therapeutics | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypertension | 71 |
| Cardiovascular Diseases | 11 |
| Diabetes Mellitus, Type 2 | 8 |
| Essential Hypertension | 7 |
| Obesity | 5 |
| Renal Insufficiency, Chronic | 5 |
| Diabetes Mellitus | 3 |
| Heart Failure | 3 |
| Overweight | 3 |
| Pulmonary Arterial Hypertension | 3 |
Trials
Showing 51 to 71 of 71. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.